| Document and Entity Information | May 18, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Form 8-K/A is filed as an amendment (“Amendment No. 1”) to the Current Report on Form 8-K filed by Ortho Clinical Diagnostics Holdings plc (“Ortho” or the “Company”) with the Securities and Exchange Commission (the “SEC”) on May 18, 2022 (the “Initial Form 8-K”). This Amendment No. 1 is being filed to amend Item 7.01 to correct a typographical error. The information set forth below under Item 7.01 replaces in its entirety the information under Item 7.01 in the Initial Form 8-K. |
| Document Period End Date | May 18, 2022 |
| Entity Registrant Name | ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC |
| Entity Central Index Key | 0001828443 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-39956 |
| Entity Tax Identification Number | 98-1574150 |
| Entity Address, Address Line One | 1001 Route 202 |
| Entity Address, City or Town | Raritan |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 08869 |
| City Area Code | 908 |
| Local Phone Number | 218-8000 |
| Title of 12(b) Security | Ordinary shares, $0.00001 par value |
| Trading Symbol | OCDX |
| Security Exchange Name | NASDAQ |
| Entity Incorporation, State or Country Code | X0 |
| Written Communications | true |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
